JP5513123B2 - ナノ粒子クラスター及びそれを形成する方法 - Google Patents

ナノ粒子クラスター及びそれを形成する方法 Download PDF

Info

Publication number
JP5513123B2
JP5513123B2 JP2009540766A JP2009540766A JP5513123B2 JP 5513123 B2 JP5513123 B2 JP 5513123B2 JP 2009540766 A JP2009540766 A JP 2009540766A JP 2009540766 A JP2009540766 A JP 2009540766A JP 5513123 B2 JP5513123 B2 JP 5513123B2
Authority
JP
Japan
Prior art keywords
nanoparticles
cluster
suspension
clusters
silica
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009540766A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512252A5 (enExample
JP2010512252A (ja
Inventor
ダーモット ブルーアム
スワパンクマール ゴーシュ
Original Assignee
ダブリン シティ ユニバーシティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ダブリン シティ ユニバーシティ filed Critical ダブリン シティ ユニバーシティ
Publication of JP2010512252A publication Critical patent/JP2010512252A/ja
Publication of JP2010512252A5 publication Critical patent/JP2010512252A5/ja
Application granted granted Critical
Publication of JP5513123B2 publication Critical patent/JP5513123B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Iron (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
JP2009540766A 2006-12-12 2007-12-12 ナノ粒子クラスター及びそれを形成する方法 Expired - Fee Related JP5513123B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06125979.2 2006-12-12
EP06125979A EP1935436A1 (en) 2006-12-12 2006-12-12 Nanoparticle clusters and methods for forming same
PCT/EP2007/063815 WO2008071742A1 (en) 2006-12-12 2007-12-12 Nanoparticle clusters and methods for forming same

Publications (3)

Publication Number Publication Date
JP2010512252A JP2010512252A (ja) 2010-04-22
JP2010512252A5 JP2010512252A5 (enExample) 2010-12-16
JP5513123B2 true JP5513123B2 (ja) 2014-06-04

Family

ID=38068568

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540766A Expired - Fee Related JP5513123B2 (ja) 2006-12-12 2007-12-12 ナノ粒子クラスター及びそれを形成する方法

Country Status (4)

Country Link
US (1) US8435496B2 (enExample)
EP (2) EP1935436A1 (enExample)
JP (1) JP5513123B2 (enExample)
WO (1) WO2008071742A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0736447Y2 (ja) 1988-12-01 1995-08-16 ニチコン株式会社 モータ過電流保護装置

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130023714A1 (en) * 2008-10-26 2013-01-24 Board Of Regents, The University Of Texas Systems Medical and Imaging Nanoclusters
US7972410B1 (en) * 2009-02-02 2011-07-05 Sandia Corporation Magnetic agglomeration method for size control in the synthesis of magnetic nanoparticles
US8565892B2 (en) * 2009-10-31 2013-10-22 Qteris, Inc. Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment
GB2476269A (en) * 2009-12-17 2011-06-22 Univ Dublin City Nanoparticle clusters formed from individual nanoparticles of two or more types
ES2582283T3 (es) 2011-08-10 2016-09-12 Magforce Ag Dispositivo médico que comprende aglomerados de nanopartículas magnéticas recubiertas con alcoxisilano
WO2013148931A1 (en) * 2012-03-28 2013-10-03 Massachusetts Institute Of Technology Multifunctional nanoparticles
ES2814336T3 (es) 2012-04-13 2021-03-26 Glaxosmithkline Ip Dev Ltd Partículas de agregado
US20150147276A1 (en) * 2012-06-07 2015-05-28 President And Fellows Of Harvard College Nanotherapeutics for drug targeting
CN110783091B (zh) * 2019-11-06 2021-03-19 安徽工业大学 一种纳米晶FeSiBCr磁粉芯的制备方法
CA3249234A1 (en) * 2022-01-19 2023-07-27 Yellowbird Diagnostics Inc METALLIC NANOPARTICLE COMPOSITIONS, THEIR MANUFACTURING PROCESSES AND THEIR USES

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346702A (en) * 1992-12-04 1994-09-13 Sterling Winthrop Inc. Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
EP0772776B1 (de) * 1994-07-27 2000-03-22 Herbert Dr. Pilgrimm Superparamagnetische teilchen, verfahren zur herstellung und deren verwendung
DE10224352A1 (de) * 2002-06-01 2003-12-11 Mueller Schulte Detlef Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie
JP4147460B2 (ja) * 2002-07-23 2008-09-10 富士通株式会社 ナノ磁性金属粒子クラスター、その製造方法、その処理方法、及び、少なくとも磁気を利用する記録媒体
US7563748B2 (en) 2003-06-23 2009-07-21 Cognis Ip Management Gmbh Alcohol alkoxylate carriers for pesticide active ingredients
JP2005048250A (ja) * 2003-07-30 2005-02-24 Dowa Mining Co Ltd 金属磁性粒子の集合体およびその製造法
US7795041B2 (en) 2004-02-11 2010-09-14 Massachusetts Institute Of Technology Multi-polymer-coated magnetic nanoclusters
JP2008510852A (ja) * 2004-08-17 2008-04-10 インヴィトロジェン コーポレーション 高発光性コロイド粒子の合成
JP2006242597A (ja) * 2005-02-28 2006-09-14 Fuji Photo Film Co Ltd 磁性体ナノ粒子の凝集・分散制御方法、磁性体ナノ粒子の捕集方法及び磁性体ナノ粒子含有液の処理方法
JP4363440B2 (ja) * 2006-11-29 2009-11-11 トヨタ自動車株式会社 ナノコンポジット磁石の製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0736447Y2 (ja) 1988-12-01 1995-08-16 ニチコン株式会社 モータ過電流保護装置

Also Published As

Publication number Publication date
US20100104514A1 (en) 2010-04-29
EP2121039B1 (en) 2012-07-11
JP2010512252A (ja) 2010-04-22
WO2008071742A1 (en) 2008-06-19
EP2121039A1 (en) 2009-11-25
US8435496B2 (en) 2013-05-07
EP1935436A1 (en) 2008-06-25

Similar Documents

Publication Publication Date Title
JP5513123B2 (ja) ナノ粒子クラスター及びそれを形成する方法
Akbarzadeh et al. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine
Sahoo et al. Aqueous ferrofluid of magnetite nanoparticles: fluorescence labeling and magnetophoretic control
Banerjee et al. Nanomedicine: magnetic nanoparticles and their biomedical applications
Jishkariani et al. Preparation and self-assembly of dendronized Janus Fe3O4–pt and Fe3O4–au heterodimers
Smith et al. Synthesis, transfer, and characterization of core-shell gold-coated magnetic nanoparticles
Yang et al. Fluorescent mesoporous silica nanotubes incorporating CdS quantum dots for controlled release of ibuprofen
JP2008501509A (ja) 非凝集性コア／シェル型ナノコンポジット粒子
Yan et al. Growth mechanism of nanostructured superparamagnetic rods obtained by electrostatic co-assembly
CN103221334B (zh) 氧化铁纳米胶囊、其制备方法和使用其的mri造影剂
WO2009021286A1 (en) Organosilica encapsulated nanoparticles
Durdureanu-Angheluta et al. Tailored and functionalized magnetite particles for biomedical and industrial applications
Chaleawlert-umpon et al. Preparation of magnetic polymer microspheres with reactive epoxide functional groups for direct immobilization of antibody
TWI374761B (en) Method for forming a drug container having the magnetic nano single-crystalline capsule
Maboudi et al. Theranostic magnetite cluster@ silica@ albumin double-shell particles as suitable carriers for water-insoluble drugs and enhanced T2 MR imaging contrast agents
Yano et al. Gadolinium-complexed carboxylated nanodiamond particles for magnetic resonance imaging of the lymphatic system
Jarouliya et al. Advances of nanotechnology in cancer therapy
El-Sherbiny et al. Physical properties, classification, synthesis, and functionalization of magnetic nanomaterials
Lu et al. Formation of polydiacetylene–NH2–gold hollow spheres and their ability in DNA immobilization
Latha et al. A review on magnetic micro/nanoparticles
Ferjaoui et al. Functional responsive superparamagnetic core/shell nanoparticles and their drug release properties
EP2512513B1 (en) Nanoparticle clusters formed from individual nanoparticles of two or more types
Stanicki et al. Iron-oxide nanoparticle-based contrast agents
Jetha et al. History of nanoparticles
Hosta-Rigau et al. Subcompartmentalized Systems Toward Therapeutic Cell Mimics

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101027

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20101027

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130619

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130626

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130627

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140225

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140327

R150 Certificate of patent or registration of utility model

Ref document number: 5513123

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees